|
Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial |
|
|
|
Title: |
Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial |
Author: |
Brown, Jennifer R Hamadani, Mehdi Hayslip, John Janssens, Ann Wagner-Johnston, Nina Ottmann, Oliver Arnason, Jon Tilly, Hervé Millenson, Michael Offner, Fritz Gabrail, Nashat Y Ganguly, Siddhartha Ailawadhi, Sikander Kasar, Siddha Kater, Arnon P Doorduijn, Jeanette K Gao, Lei Lager, Joanne J Wu, Bin Egile, Coumaran Kersten, Marie José |
Appeared in: |
The Lancet. Haematology |
Paging: |
Volume 5 (2018) nr. 4 pages e170-e180 |
Year: |
2018 |
Contents: |
|
Publisher: |
Elsevier Ltd |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|